Pharmacogenomics · 2012 · 33 citations · 29 references
Veterinary MedicineGeneticsPharmacologyHuman GeneticsPharmacogeneticsPharmacogenomicsDrug Metabolism GeneticsPharmacogenetic TestingPopulation PharmacogeneticsPsychiatric GeneticsWithdrawal SyndromesDrug Metabolism PolymorphismsGenetic PolymorphismsMethadone Maintenance TherapyMethadone Maintenance TreatmentSubstance Use Disorder GeneticsSubstance Use GeneticsWithdrawal Symptoms
AIM: To test whether the genetic polymorphisms within the gene encoding the UGT2B7 gene may have an impact on methadone treatment. MATERIALS & METHODS: Twelve SNPs in UGT2B7 were selected. 366 methadone maintenance treatment patients in Taiwan were recruited and genotyped. RESULTS: In a genotype recessive model, rs6600879, rs6600880, rs4554144, rs11940316, rs7438135, rs7662029, rs7668258, rs7439366, rs4292394 and rs6600893 showed significant associations with severity of withdrawal symptoms (permutation p < 0.002), pupil size (permutation p < 0.048) and tremor (permutation p < 0.008). Haplotypes of GATCAGCCGC and CTCTGATTCT were significantly associated with pupil size score and tremor score (p < 0.034). CONCLUSION: These results suggest that SNPs of the UGT2B7 gene may play important roles in opiate withdrawal symptoms.
29
Haploview: analysis and visualization of LD and haplotype maps
Jeffrey C. Barrett, Ben Fry, Julian Maller et al. · Bioinformatics · 2004 · 14.7K citations · Full text
The Structure of Haplotype Blocks in the Human Genome
Stacey Gabriel, S. F. Schaffner, Huy Nguyen et al. · Science · 2002 · 5.9K citations